ML20135B220

Forwards Rept from CDC to Frpcc on Use of Potassium Iodide

ML20135B220
Person / Time
Issue date:	10/16/1990
From:	Heltemes J NRC
To:	Thompson H NRC
Shared Package
ML20135B134	List: ML20135B199 ML20135B203 ML20135B207 ML20135B210 ML20135B215 ML20135B217 ML20135B220 ML20135B229 ML20135B232 ML20135B235 ML20135B243 ML20135B249 ML20135B262 ML20135B897 ML20135B906 ML20135B916 ML20135B935 ML20135B980 ML20135C094 ML20135C248 ML20135C255 ML20135C261 NUREG/CR-1433, Reassigns Differing Professional Opinion Position to RES for Informal Review IAW Mc 4125.Key Issue Raised in Adequacy of cost-benefit Conclusion Originally Made in NUREG/CR-1433 & Adoption/Endorsement by NUREG-1355 & NUREG-1251 Discuss
References
NUDOCS 9702280135
Download: ML20135B220 (1)

Text

. _-

p.

.. l

/

October 16, 1990 4

NOTE T0: Hugh Thompson ,

FRON: Jack Heltemes Enclosed for your information is the report from the CDC to the FRPCC on ,

4 the use of potassium iodide. Please note that the recommendation to the FRPCC r i e

is three-fold: (1) that the guicance need not be changec; (2) that the existing j store of KI should be inventoried; and (3) a working group should be establisheo

, to further adoress the issue of stockpiling and to make final recommendations ]

regarding the Federal policy. .

Jc 'e'm2

Enclosure:

As stated cc w/ enclosure:

P. Rathbun P. Crane E. Beckjord T. Speis ,

B. Morris R. Bernero i D. Cunningham F. Corgel -

E. Podulak . I E. Jordan L. Spessato R. Hogan

.I r'y1 9702280135 PDR ORG 970226 NIRCTN PDR